These Numbers Could Change Investor Views For Poseida Therapeutics Inc (NASDAQ: PSTX)
Currently, there are 85.96M common shares owned by the public and among those 61.72M shares have been available to trade. Insiders at the company have transacted a total of 14 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 11 of these insider trades were purchases, […]
